{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":253,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":253,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"d7116a3a9363","filters":{"venue":"Leukemia Research"}},"results":[{"id":"W2136112505","doi":"10.1016/j.leukres.2008.06.028","title":"In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":354,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; In vivo; Pharmacology; Drug; Therapeutic index; Medicine; Chemistry; Leukemia; Immunology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05281627163083522,"gpt":0.32778969499979,"spread":0.2749734233689548,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001919879,0.0001959575,0.0003936248,0.0003594101,0.0002021713,0.00004007066,0.0007159449,0.0001078117,0.001101731],"category_scores_gemma":[0.000641061,0.0001672495,0.0000704524,0.00111284,0.0009053444,0.0003275081,0.0001555461,0.0004017654,0.0006256951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007778662,"about_ca_system_score_gemma":0.001007034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001584445,"about_ca_topic_score_gemma":0.0001760772,"domain_scores_codex":[0.9961292,0.0006563672,0.0005851375,0.0005557728,0.001134823,0.0009386781],"domain_scores_gemma":[0.9974779,0.001230189,0.0001096115,0.0006864637,0.0003532883,0.0001425313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000369694,0.0001644362,0.000718674,0.00005536303,0.000006261479,0.0002392035,0.0006499421,0.001187508,0.9926158,0.001124123,0.002678027,0.0001910196],"study_design_scores_gemma":[0.001432924,0.0002472792,0.00200251,0.0001099102,0.000004938733,0.00001976148,0.0001287666,0.001448838,0.9932966,0.0005093275,0.0006195988,0.0001795165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967484,0.0003433086,0.0002221792,0.0003760302,0.0001790274,0.0004863816,0.00001466941,0.00004839134,0.001581545],"genre_scores_gemma":[0.996109,0.000154723,0.00035719,0.0001228051,0.0001075101,0.00008386537,0.00000163362,0.00002928081,0.003033979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002058428,"threshold_uncertainty_score":0.9998114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062483137","doi":"10.1016/j.leukres.2004.01.006","title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD34; Pathology; Chemotherapy; Myeloid; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1143063588133743,"gpt":0.4185228793817654,"spread":0.304216520568391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004598382,0.0003394356,0.001045011,0.0006101102,0.0002866521,0.00009565098,0.0004501177,0.0005644221,0.0001764526],"category_scores_gemma":[0.005812599,0.0002484699,0.0001544726,0.001107294,0.00217598,0.0003117665,0.0004753663,0.002816072,0.00005267059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001752519,"about_ca_system_score_gemma":0.00374401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008240283,"about_ca_topic_score_gemma":0.0002108099,"domain_scores_codex":[0.994211,0.0007050259,0.001107569,0.0007033002,0.002069201,0.001203879],"domain_scores_gemma":[0.9945666,0.002117798,0.0002617648,0.0009011891,0.001427686,0.0007250134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001497345,0.0003345178,0.9872792,0.0005138368,0.0002306254,0.0008233376,0.0007408087,0.00004852997,0.004329997,0.0007447249,0.002282525,0.001174487],"study_design_scores_gemma":[0.0132781,0.002493337,0.9581312,0.002042811,0.00007886984,0.0003493884,0.0039371,0.0001926175,0.01630938,0.001254485,0.001488365,0.0004443325],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940593,0.0008677325,0.00007483004,0.001502556,0.00005488762,0.0009712217,0.00004952595,0.0001139013,0.002306033],"genre_scores_gemma":[0.9945273,0.0007074814,0.00180008,0.0003030067,0.0002099736,0.0001048658,0.00006331953,0.0000865025,0.002197429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02914806,"threshold_uncertainty_score":0.9999968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993701888","doi":"10.1016/j.leukres.2009.06.019","title":"CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Myeloid leukemia; CpG site; Myelodysplastic syndromes; MEG3; DNA methylation; Internal medicine; Biology; Cancer research; Oncology; Medicine; Bone marrow; Gene; Genetics; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.02601831062187594,"gpt":0.3329641626405612,"spread":0.3069458520186852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009199708,0.0001269303,0.0002293973,0.0003616042,0.0001087147,0.00003710818,0.0001879276,0.0001886475,0.000008584432],"category_scores_gemma":[0.0002360014,0.00009921037,0.00007149545,0.000942594,0.0001762887,0.000007375923,0.000180774,0.00021851,7.221867e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001268393,"about_ca_system_score_gemma":0.0002168029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002223323,"about_ca_topic_score_gemma":0.0003011443,"domain_scores_codex":[0.9984667,0.0002677966,0.0002811072,0.0003784542,0.0003232327,0.000282663],"domain_scores_gemma":[0.9992041,0.0001100096,0.00007714498,0.0003682048,0.0001653708,0.00007516626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00007313542,0.00001389758,0.02308406,0.00001485348,0.0002228907,0.000002587459,0.0001080181,0.0009617769,0.959572,0.0002340489,0.00001230862,0.01570048],"study_design_scores_gemma":[0.0004670861,0.0002095112,0.5780483,0.00001493199,0.0001389143,0.000002849435,0.00005860785,0.008500904,0.4112385,0.0008313274,0.0003694746,0.0001195217],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957427,0.00289726,0.0006579238,0.0001611748,0.00002696132,0.0002024244,0.0000123884,0.000003995757,0.0002951201],"genre_scores_gemma":[0.9964101,0.002881558,0.0003145896,0.00002218081,0.00002874302,0.00001432633,0.00003816719,0.000009869123,0.000280459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5549643,"threshold_uncertainty_score":0.4045681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082440968","doi":"10.1016/j.leukres.2010.01.015","title":"Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Leukemia; Bone marrow; Pharmacology; Medicine; Cancer research; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.03156372451505941,"gpt":0.3355735905415375,"spread":0.3040098660264781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004807284,0.0004937109,0.001087963,0.001987168,0.0003688974,0.0001057426,0.0005523075,0.0007479229,0.0002845616],"category_scores_gemma":[0.005038418,0.0004551588,0.0001760503,0.003118782,0.001059255,0.0004299929,0.0005218399,0.004642213,0.00008698744],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004364522,"about_ca_system_score_gemma":0.005849333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004972399,"about_ca_topic_score_gemma":0.003796269,"domain_scores_codex":[0.9931644,0.0005089282,0.001220624,0.001151454,0.002214433,0.001740163],"domain_scores_gemma":[0.9946932,0.001525239,0.0002135391,0.001265198,0.001590415,0.0007123873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002265485,0.0002698106,0.03983628,0.0006584974,0.0001296874,0.0004856888,0.001435883,0.000168087,0.9380713,0.005092927,0.006626303,0.00496011],"study_design_scores_gemma":[0.0169406,0.002393414,0.4959524,0.0006905761,0.0001124132,0.000563626,0.001056473,0.06406439,0.4099419,0.003732534,0.003491952,0.001059735],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894969,0.0003780947,0.0003253883,0.001004136,0.0001251324,0.002252297,0.00004586836,0.00009720262,0.006274956],"genre_scores_gemma":[0.9928117,0.0002320354,0.002728771,0.0001409358,0.0004584781,0.0003140074,0.0001061977,0.0001154889,0.003092361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5281293,"threshold_uncertainty_score":0.99979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016908144","doi":"10.1016/j.leukres.2014.01.004","title":"Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Leukapheresis; Myeloid leukemia; Meta-analysis; Chemotherapy; Leukocytosis; Oncology; Leukostasis; Leukemia; Internal medicine; Intensive care medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1378120852896447,"gpt":0.4313074187190795,"spread":0.2934953334294348,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01807012,0.002215407,0.0263742,0.004144749,0.0004660345,0.0006800392,0.002050822,0.001913603,0.0006437144],"category_scores_gemma":[0.002717624,0.00156916,0.004374202,0.008973461,0.001412707,0.0004315025,0.001413979,0.006941774,0.0003639003],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01109972,"about_ca_system_score_gemma":0.008152306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003659764,"about_ca_topic_score_gemma":0.0002541442,"domain_scores_codex":[0.9772568,0.007205558,0.004449086,0.003844279,0.004407551,0.002836688],"domain_scores_gemma":[0.9874259,0.003151915,0.001214525,0.005381615,0.00117214,0.001653924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001606837,0.00009910542,0.00003373264,0.8210238,0.1676722,0.0006813572,0.0002057407,8.225412e-7,0.00002521633,0.00009980429,0.001510053,0.0084875],"study_design_scores_gemma":[0.002992986,0.0005141669,0.0003927176,0.1076932,0.8686355,0.0008106356,0.0001101493,0.0001960087,0.00003461337,0.0000688547,0.0167258,0.0018253],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003223473,0.9800175,0.000009219495,0.0008108089,0.00003294455,0.0146775,0.0002434663,0.0001493833,0.0008356548],"genre_scores_gemma":[0.001532007,0.9808933,0.0003815156,0.001141981,0.0001823513,0.006543647,0.0002285943,0.0004432654,0.00865336],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7133305,"threshold_uncertainty_score":0.9993821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980393873","doi":"10.1016/j.leukres.2013.02.009","title":"Symptom burden and supportive care in patients with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Sadness; Referral; Psychosocial; Acute leukemia; Population; Palliative care; Anger; Leukemia; Psychiatry; Physical therapy; Pediatrics; Intensive care medicine; Internal medicine; Family medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.05923042890475087,"gpt":0.4083879097847791,"spread":0.3491574808800282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002021298,0.0001454624,0.0003426457,0.0003053761,0.00005335981,0.00002511245,0.00012788,0.0001266447,0.0001564204],"category_scores_gemma":[0.0001766052,0.0001064413,0.00003240422,0.0004369666,0.000280288,0.000156566,0.0001243692,0.0005168964,0.00008091254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001323352,"about_ca_system_score_gemma":0.0008631615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003375815,"about_ca_topic_score_gemma":0.00008851085,"domain_scores_codex":[0.9980994,0.0001011239,0.0002315757,0.0003289734,0.0007509665,0.0004879764],"domain_scores_gemma":[0.9983608,0.0002092431,0.00003472785,0.0003066353,0.000879648,0.0002089508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006714866,0.00002587283,0.9752883,0.0002722988,0.0001305228,0.0001075712,0.008916164,0.000005715675,0.0006861467,0.0000607925,0.002215699,0.01161947],"study_design_scores_gemma":[0.006867966,0.001865163,0.9724255,0.001165021,0.0000440303,0.000003841751,0.006925865,0.0001501042,0.00561682,0.00008827098,0.004642022,0.0002053648],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992103,0.0006044483,0.000003815316,0.00025102,0.00002018211,0.0007719307,0.00001750849,0.00001852595,0.006209615],"genre_scores_gemma":[0.9979745,0.0003295345,0.0005350174,0.00005252463,0.00008443116,0.00008457046,0.00007133815,0.00002591763,0.0008422312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0114141,"threshold_uncertainty_score":0.5103244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034409643","doi":"10.1016/s0145-2126(03)00180-2","title":"Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunophenotyping; CD33; Medicine; Internal medicine; Gastroenterology; CD34; Acute promyelocytic leukemia; Myeloid leukemia; Daunorubicin; Leukemia; Oncology; Immunology; Flow cytometry; Biology; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.02573849786091874,"gpt":0.3181297772763707,"spread":0.2923912794154519,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002677717,0.0004112327,0.0008557763,0.001219556,0.0002258827,0.00005725174,0.0006397291,0.0003592185,0.0002238095],"category_scores_gemma":[0.003758433,0.0003373247,0.000123906,0.003433388,0.0008345855,0.0003239535,0.0002809878,0.002855461,0.0002168277],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008162766,"about_ca_system_score_gemma":0.008023709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009059799,"about_ca_topic_score_gemma":0.0001112363,"domain_scores_codex":[0.9929958,0.000714699,0.0008559453,0.0009574136,0.002626605,0.001849514],"domain_scores_gemma":[0.9951745,0.00135353,0.0001218354,0.001361107,0.001562154,0.0004269123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01025577,0.001121652,0.8911251,0.001759116,0.0008212446,0.001895502,0.002552668,0.0005059723,0.05658234,0.006419802,0.003838889,0.0231219],"study_design_scores_gemma":[0.03404989,0.004974811,0.8827627,0.002975917,0.0001885309,0.000262075,0.0009112284,0.002334147,0.05499669,0.001787839,0.01353386,0.001222304],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828005,0.0005801026,0.0001153147,0.0002004544,0.00007250297,0.002373061,0.00002332245,0.00006960905,0.01376514],"genre_scores_gemma":[0.9910243,0.0004329317,0.005345494,0.00009810543,0.00006549537,0.0002829567,0.00008618139,0.0001397215,0.002524815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02379412,"threshold_uncertainty_score":0.9999079,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156134411","doi":"10.1016/s0145-2126(02)00222-9","title":"Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trichostatin A; Histone deacetylase; DNA methylation; Cancer research; Azacitidine; Acetylation; Histone deacetylase inhibitor; Histone; Decitabine; Myeloid leukemia; Epigenetics; CpG site; Deoxycytidine; Chromatin; Biology; Chemistry; DNA; Biochemistry; Gene expression; Chemotherapy; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.06027886334873608,"gpt":0.3861331952723275,"spread":0.3258543319235914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006175546,0.0001388842,0.0002827686,0.0003971881,0.00004948827,0.000008220848,0.0001034665,0.0002805912,0.000007260238],"category_scores_gemma":[0.003049951,0.0001498402,0.00006340658,0.0005588879,0.0002047002,0.00002048961,0.00006674667,0.0002424782,7.462243e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002934154,"about_ca_system_score_gemma":0.0007840238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001706512,"about_ca_topic_score_gemma":0.0001217952,"domain_scores_codex":[0.9964519,0.0013602,0.0007106712,0.0003816808,0.0008602814,0.0002352533],"domain_scores_gemma":[0.9977325,0.0004852347,0.0004183711,0.0002964937,0.001004622,0.00006273014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001661166,0.0001457919,0.01091667,0.0001151201,0.00001964824,1.916639e-7,0.0001629292,0.0056817,0.9654173,0.00008940879,0.00001509458,0.01727004],"study_design_scores_gemma":[0.002059483,0.0004120163,0.06621657,0.0000617914,0.00002412012,3.199559e-7,0.00007088638,0.01525205,0.9152125,0.0005427608,0.00003746186,0.0001101094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959224,0.001105983,0.001757367,0.00001647125,0.00007922605,0.0006371953,0.00001146696,0.000003208547,0.0004666604],"genre_scores_gemma":[0.9980701,0.0007400989,0.0009992899,0.000001985964,0.00002568125,0.00002514063,0.00007832811,0.00001968947,0.00003974526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05529989,"threshold_uncertainty_score":0.6110307,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971888832","doi":"10.1016/j.leukres.2010.07.015","title":"What are RBC-transfusion-dependence and -independence?","year":2010,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Independence (probability theory); Medicine; Erythropoiesis; Anemia; Intensive care medicine; Interval (graph theory); Transfusion therapy; Blood transfusion; Internal medicine; Statistics; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.06272011493768677,"gpt":0.3645420701961772,"spread":0.3018219552584905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001211763,0.0005831043,0.0009564132,0.0006543685,0.0005116618,0.0005656393,0.0004173342,0.003527953,0.001527854],"category_scores_gemma":[0.0004412581,0.0004460426,0.000202289,0.0004723245,0.0005572141,0.0003623445,0.0003072671,0.01813899,0.0006734915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001057197,"about_ca_system_score_gemma":0.001839594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009999553,"about_ca_topic_score_gemma":0.0008360243,"domain_scores_codex":[0.9931269,0.0003895808,0.0004606228,0.001441705,0.003333519,0.001247704],"domain_scores_gemma":[0.9959486,0.001344585,0.0001278812,0.001166235,0.0009791043,0.0004336318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001830496,0.0001379906,0.01580166,0.0008167987,0.0002559681,0.01469663,0.0004756704,3.797196e-7,0.0007879573,0.00009306872,0.954286,0.0124648],"study_design_scores_gemma":[0.002970439,0.0008323729,0.01455066,0.002752965,0.0001875636,0.001373294,0.0005092337,0.00007366413,0.005482008,0.001083617,0.9695216,0.0006625361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.12762,0.004180749,0.000009679702,0.8591647,0.001126557,0.002631917,0.00006891364,0.000112443,0.005085106],"genre_scores_gemma":[0.1040712,0.09630194,0.001444672,0.6722732,0.01545761,0.002880414,0.0008986783,0.0005381157,0.1061341],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1868914,"threshold_uncertainty_score":0.9997991,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999705499","doi":"10.1016/j.leukres.2012.07.006","title":"Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Pharmacokinetics; Medicine; Pharmacology; Leukemia; Liposome; Internal medicine; Drug; Chemotherapy; Gastroenterology; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02385902470215748,"gpt":0.3293869841911375,"spread":0.30552795948898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002015437,0.0003748362,0.0008709253,0.001190176,0.0001267857,0.00001976178,0.000488052,0.0003422859,0.0002492145],"category_scores_gemma":[0.0006367142,0.0003120447,0.0001389978,0.002298125,0.0004439295,0.0006449934,0.0003340159,0.001514408,0.00005100562],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004495393,"about_ca_system_score_gemma":0.002503033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006372105,"about_ca_topic_score_gemma":0.00005909718,"domain_scores_codex":[0.9936764,0.0004569968,0.001044316,0.0005571884,0.002735723,0.001529333],"domain_scores_gemma":[0.996003,0.0005637767,0.000215519,0.0009553961,0.001758633,0.0005036279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009057391,0.0008120222,0.6098202,0.0009142379,0.0001485987,0.00001890408,0.001666652,0.001173522,0.3666702,0.0002622687,0.001163174,0.008292822],"study_design_scores_gemma":[0.02086429,0.002384193,0.5539483,0.0005211706,0.00007272643,0.00001332615,0.0003363244,0.006721143,0.4136959,0.00003782112,0.001057029,0.0003477118],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946169,0.0003729826,0.0002128598,0.0001623494,0.00008503176,0.002387998,0.00004909947,0.00004164239,0.002071182],"genre_scores_gemma":[0.9947579,0.0001477947,0.003672459,0.0000617054,0.0001832543,0.0001422822,0.0002305366,0.0001054545,0.0006985965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05587187,"threshold_uncertainty_score":0.9999332,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099334882","doi":"10.1016/j.leukres.2006.08.002","title":"Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Research Society","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Fluorescence in situ hybridization; Refractory (planetary science); Medicine; Gastroenterology; Salvage therapy; Oncology; Cytogenetics; Chemotherapy; Biology; Chromosome","retraction":null,"screen_n_in":null,"score":{"opus":0.06428577554715627,"gpt":0.3601911205293414,"spread":0.2959053449821852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002666363,0.0002669778,0.0005220728,0.0011852,0.0001506073,0.00004077084,0.0003438591,0.0002878496,0.0005232289],"category_scores_gemma":[0.000661671,0.000224027,0.0001716422,0.0009212669,0.0004497646,0.0001041675,0.0001768594,0.001012758,0.0001740876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001747181,"about_ca_system_score_gemma":0.001916113,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01088992,"about_ca_topic_score_gemma":0.0008078882,"domain_scores_codex":[0.9945251,0.0009883229,0.0006654078,0.0005739541,0.002102864,0.00114438],"domain_scores_gemma":[0.9968174,0.001396848,0.00009207986,0.0008988556,0.0004936719,0.0003011829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03582802,0.001368854,0.787151,0.0001990516,0.0001642506,0.001762258,0.001288312,0.00006219505,0.153312,0.0001434549,0.003058784,0.01566179],"study_design_scores_gemma":[0.01481323,0.001485201,0.8462777,0.000160023,0.000006909776,0.00005229935,0.0005288211,0.0007380101,0.1309707,0.0003187874,0.004475674,0.0001726508],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917893,0.002281772,0.000005756106,0.000484232,0.00004200081,0.001229542,0.00006052324,0.00004042871,0.004066409],"genre_scores_gemma":[0.990617,0.0006061671,0.0003770035,0.00007348635,0.0001247831,0.0002159161,0.00005311101,0.00005974565,0.007872807],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05912662,"threshold_uncertainty_score":0.9956967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089243465","doi":"10.1016/j.leukres.2011.07.033","title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"North York General Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"Medical Center, University of Rochester; University of Toronto; European Hematology Association","keywords":"Presentation (obstetrics); Context (archaeology); Lineage (genetic); Neoplasm; Expression (computer science); Pathology; Medicine; Biology; Gene; Computer science; Genetics; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.07700582834842269,"gpt":0.3829620155647267,"spread":0.305956187216304,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001226771,0.001154672,0.002998241,0.001406105,0.0007429142,0.0004495162,0.0006064596,0.0007389367,0.0003651308],"category_scores_gemma":[0.001067787,0.0008634957,0.0003779046,0.002725529,0.00112997,0.0003459108,0.0006708262,0.004147772,0.0003374143],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003070486,"about_ca_system_score_gemma":0.007348052,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003794269,"about_ca_topic_score_gemma":0.0004773219,"domain_scores_codex":[0.9916342,0.001537636,0.001249028,0.001791477,0.001975599,0.001812023],"domain_scores_gemma":[0.9938493,0.001613125,0.0003241689,0.001465677,0.001830868,0.0009168232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"case_report","study_design_scores_codex":[0.0006816425,0.0002425021,0.000107624,0.5926275,0.0006925677,0.2255358,0.00160154,0.000001667895,0.00001731884,0.000196653,0.007745662,0.1705495],"study_design_scores_gemma":[0.001141124,0.001145663,4.444242e-7,0.1488808,0.0008902202,0.4530891,0.0003770316,0.00004292243,0.0000301796,0.0000547099,0.3937563,0.0005915184],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001075665,0.9877615,0.00001019871,0.0001021499,0.00007865101,0.006921344,0.0001617189,0.0001245576,0.003764188],"genre_scores_gemma":[0.0002660598,0.9809079,0.0004551083,0.0001472103,0.0002726223,0.0008619901,0.0006673172,0.0003397491,0.01608201],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4437467,"threshold_uncertainty_score":0.9993816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014246201","doi":"10.1016/j.leukres.2008.08.021","title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trillium Therapeutics (Canada)","funders":"José Carreras Leukämie-Stiftung","keywords":"Blockade; Chronic lymphocytic leukemia; Cancer research; Leukemia; T cell; Immunology; Medicine; Internal medicine; Receptor; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.04986831443506784,"gpt":0.357106477950665,"spread":0.3072381635155971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001998233,0.0004273623,0.0009022725,0.001177808,0.0002987034,0.0000329453,0.0007771854,0.0006297109,0.0007111147],"category_scores_gemma":[0.0006236436,0.0003858259,0.0002401205,0.002376984,0.001221162,0.0002750346,0.0005730065,0.00180301,0.0005559556],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.3450629,"about_ca_system_score_gemma":0.1249546,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01178997,"about_ca_topic_score_gemma":0.0001450249,"domain_scores_codex":[0.991921,0.0005814981,0.001067105,0.001075676,0.003341489,0.00201325],"domain_scores_gemma":[0.9962052,0.0009220201,0.0001581266,0.001519828,0.0005394506,0.0006554155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002328381,0.0002530142,0.002335337,0.002073811,0.00006769828,0.002116943,0.001350155,0.002587431,0.9372962,0.00009506488,0.04724627,0.002249677],"study_design_scores_gemma":[0.04813125,0.001519223,0.003111269,0.001034427,0.00003772446,0.00102425,0.0003577148,0.1668243,0.7643595,0.0001353363,0.01291239,0.000552597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836377,0.003196042,0.00004692714,0.0001149614,0.000112932,0.001409708,0.00002987282,0.0001008236,0.01135104],"genre_scores_gemma":[0.9790537,0.003331741,0.0002814821,0.00004839274,0.0003260118,0.000185537,0.0001439098,0.000120198,0.01650906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2201083,"threshold_uncertainty_score":0.9998594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1142333440","doi":"10.1016/j.leukres.2015.08.012","title":"A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of Alberta; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Randomized controlled trial; Aerobic exercise; Induction chemotherapy; Quality of life (healthcare); Physical therapy; Internal medicine; Grip strength; Myeloid leukemia; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.04461839989931244,"gpt":0.3640978572054129,"spread":0.3194794573061004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003481226,0.0002802258,0.001570883,0.0004023336,0.0003061554,0.00008471364,0.0001909674,0.0002485283,0.00007288452],"category_scores_gemma":[0.001015214,0.0001880228,0.0003764947,0.0005752599,0.0002717365,0.0001941467,0.00006591865,0.0006188205,0.00001552776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003093739,"about_ca_system_score_gemma":0.005479149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006229158,"about_ca_topic_score_gemma":0.0001919757,"domain_scores_codex":[0.9963118,0.0003846636,0.0005597582,0.0005283986,0.001525004,0.0006903755],"domain_scores_gemma":[0.9966767,0.0007601207,0.0001720817,0.0005013447,0.00143699,0.000452769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9791911,0.0006125664,0.00001903322,0.00007418397,0.0005140243,0.00001346778,0.002209192,0.000006170762,0.0001616299,0.0000918797,0.005856702,0.0112501],"study_design_scores_gemma":[0.9833801,0.009508917,0.000005789357,0.000225123,0.0003732884,0.000005503059,0.0006725093,0.0007925843,0.0009532126,0.0004768842,0.00339491,0.0002111999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806971,0.0002799934,0.0005587487,0.0008567374,0.0006986973,0.0147717,0.00001649624,0.00009514044,0.002025424],"genre_scores_gemma":[0.9836501,0.0003014471,0.0003415003,0.0001934215,0.0009104211,0.005053352,0.0001832432,0.00008766016,0.009278852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0110389,"threshold_uncertainty_score":0.9719775,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102107035","doi":"10.1016/j.leukres.2006.10.001","title":"Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Myeloid leukemia; Cancer research; Matrix metalloproteinase; Angiogenesis; Leukemia; Catechin; Secretion; Myeloid; Epicatechin gallate; Epigallocatechin gallate; Chemistry; Biology; Molecular biology; Immunology; Biochemistry; Polyphenol","retraction":null,"screen_n_in":null,"score":{"opus":0.01868978015668817,"gpt":0.2930560255391705,"spread":0.2743662453824824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008371517,0.000285641,0.0005382085,0.0005392153,0.0001498562,0.00004810422,0.0001662315,0.0003907457,0.0001998539],"category_scores_gemma":[0.00009144742,0.0002457692,0.00008356934,0.0007458369,0.0003226574,0.0001562814,0.0002489836,0.001060929,0.00006543432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001151223,"about_ca_system_score_gemma":0.0004319074,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01614046,"about_ca_topic_score_gemma":0.0002928429,"domain_scores_codex":[0.9965405,0.0003886121,0.0005617166,0.0006030194,0.001020981,0.0008851163],"domain_scores_gemma":[0.9986807,0.0002621558,0.0001147518,0.0005034942,0.0001756046,0.000263338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005386515,0.0001726316,0.00742137,0.0005316735,0.00001464269,0.0001898382,0.0003405297,0.00001576689,0.973076,0.00004608315,0.01388008,0.003772689],"study_design_scores_gemma":[0.005665748,0.00051571,0.08302626,0.0007331618,0.00002213196,0.00002394076,0.0002267326,0.001338515,0.9070503,0.0005158035,0.0006367788,0.000244988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943662,0.001595963,0.0000522165,0.0002267095,0.00006558545,0.0008690688,0.00004799818,0.00007006467,0.002706137],"genre_scores_gemma":[0.9950532,0.0001491338,0.0003128822,0.00006882173,0.0001888208,0.00006549688,0.0001558786,0.00006575905,0.003940053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07560489,"threshold_uncertainty_score":0.9999995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980663284","doi":"10.1016/j.leukres.2008.07.015","title":"Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Michael Smith Health Research BC","keywords":"Imatinib; Myeloid leukemia; Internal medicine; Medicine; Odds ratio; Gastroenterology; Trough (economics); Trough level; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.06151900886646074,"gpt":0.3415745133581233,"spread":0.2800555044916626,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001225894,0.000456738,0.0008852287,0.0007766553,0.0003141538,0.00005576521,0.0002251417,0.0003008168,0.00007713517],"category_scores_gemma":[0.0009617398,0.0003723259,0.000073936,0.001030983,0.0008130189,0.0001860375,0.0001925801,0.001052467,0.00002211753],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007669998,"about_ca_system_score_gemma":0.007481933,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002128836,"about_ca_topic_score_gemma":0.0005148076,"domain_scores_codex":[0.9950973,0.000706428,0.0008221332,0.0009039193,0.001553312,0.0009169043],"domain_scores_gemma":[0.9971502,0.0008943166,0.0002831529,0.0007758366,0.000492167,0.0004042803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.06916568,0.0002927202,0.2138535,0.0009409738,0.0007254977,0.004215035,0.01030466,0.002729794,0.6630527,0.0001208785,0.000494022,0.0341045],"study_design_scores_gemma":[0.03687789,0.006045182,0.5341045,0.001194366,0.00007250478,0.0009426218,0.0008136121,0.008398668,0.4108248,0.00007672095,0.0001814612,0.0004677114],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994714,0.001928724,0.0001207654,0.0003213575,0.00002798533,0.002419511,0.0002093073,0.0000595635,0.0001988212],"genre_scores_gemma":[0.99285,0.002866139,0.003266789,0.00007929457,0.00006133118,0.0002454015,0.00004053827,0.00009915381,0.0004913203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3202509,"threshold_uncertainty_score":0.9998729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036608644","doi":"10.1016/s0145-2126(07)70460-5","title":"Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy","year":2007,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Internal medicine; Chelation therapy; Overall survival; Bone marrow; Thalassemia","retraction":null,"screen_n_in":null,"score":{"opus":0.1451629457417188,"gpt":0.447201765059812,"spread":0.3020388193180932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00257867,0.0004267541,0.001636484,0.0008726018,0.0001592331,0.00005603376,0.0001705848,0.001185085,0.00003881018],"category_scores_gemma":[0.0004574237,0.0002842501,0.0001899757,0.0009819162,0.0003451276,0.0001161818,0.000148389,0.003475931,0.00004173432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001863636,"about_ca_system_score_gemma":0.00138774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004331806,"about_ca_topic_score_gemma":0.00001514935,"domain_scores_codex":[0.9956103,0.0004721776,0.001204166,0.0007726179,0.001086447,0.0008542905],"domain_scores_gemma":[0.9980108,0.0007495807,0.0002712087,0.0004880673,0.0001725926,0.0003078081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003908532,0.0001928046,0.06343602,0.009585987,0.00007093886,0.0002610925,0.00004633516,0.000008300418,5.518282e-7,0.000007743054,0.00001106496,0.9259883],"study_design_scores_gemma":[0.05108697,0.01245309,0.4591301,0.0992388,0.001824933,0.0009652175,0.0003724323,0.004351463,7.322237e-7,0.00003018472,0.3673778,0.003168229],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3626168,0.6349874,0.00001353558,0.00001156354,0.0001290507,0.001987227,0.000007023286,0.00002613097,0.0002212074],"genre_scores_gemma":[0.01319049,0.9858034,0.0003114558,0.00003341931,0.0001021065,0.00002776229,0.0001172905,0.0001184449,0.000295625],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9228201,"threshold_uncertainty_score":0.999961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074908346","doi":"10.1016/j.leukres.2012.12.007","title":"Abducted by the illness: A qualitative study of traumatic stress in individuals with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"York University; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; University Health Network","keywords":"Traumatic stress; Qualitative research; Psychological intervention; Grounded theory; Medicine; Clinical psychology; Preference; Population; Psychiatry; Leukemia; Acute leukemia; Psychology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07244435580026112,"gpt":0.4215284975666684,"spread":0.3490841417664072,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004236418,0.0002996225,0.000847633,0.0004786652,0.0002044308,0.0000863,0.0007041437,0.0001358304,0.0002102877],"category_scores_gemma":[0.0006707142,0.0001876044,0.00007371124,0.001957137,0.0006458668,0.0002612415,0.0002214075,0.001518037,0.00007321109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001441575,"about_ca_system_score_gemma":0.001704099,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05744027,"about_ca_topic_score_gemma":0.005302107,"domain_scores_codex":[0.9921704,0.002774559,0.0008072253,0.0005990581,0.002845544,0.0008032005],"domain_scores_gemma":[0.9953008,0.002515764,0.0001749477,0.001115878,0.0006468447,0.0002457605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"qualitative","study_design_scores_codex":[0.0004089596,0.001534517,0.01776696,0.0004789732,0.0008700961,0.00004827028,0.9635823,0.0000388555,0.001399178,0.000135429,0.01188655,0.001849949],"study_design_scores_gemma":[0.009606932,0.003251333,0.06742889,0.0007419476,0.0001168398,0.00003031412,0.9137115,0.0003018541,0.00373767,0.0005959729,0.0001524628,0.0003242708],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919887,0.0002229939,0.00001116281,0.002411508,0.00003480503,0.00411076,0.00007055883,0.00004663607,0.001102911],"genre_scores_gemma":[0.9976051,0.000031633,0.0001366674,0.0001794556,0.00008414227,0.0009779,0.00004683463,0.00005916149,0.0008790985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05213816,"threshold_uncertainty_score":0.9488363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017649143","doi":"10.1016/j.leukres.2012.05.016","title":"A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University Health Network; University of Toronto; Toronto Rehabilitation Institute","funders":"National Institute on Aging; Toronto Rehabilitation Institute","keywords":"Medicine; Myeloid leukemia; Induction chemotherapy; Randomized controlled trial; Physical therapy; Quality of life (healthcare); Clinical trial; Internal medicine; Physical fitness; Population; Oncology; Chemotherapy; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09383302063113753,"gpt":0.4095239671299657,"spread":0.3156909464988282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001939246,0.0002015769,0.0005865661,0.0002789359,0.0001432804,0.0000262821,0.0002142155,0.0003359035,0.00008073824],"category_scores_gemma":[0.000419059,0.0001584296,0.0002269009,0.0006694904,0.0002691975,0.0002374714,0.00007165119,0.0007721702,0.00001770851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001434072,"about_ca_system_score_gemma":0.00259116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0010396,"about_ca_topic_score_gemma":0.0003963562,"domain_scores_codex":[0.9968887,0.0002140747,0.0005915244,0.0004140066,0.001126441,0.0007652839],"domain_scores_gemma":[0.9972777,0.0004600356,0.000131173,0.0006041529,0.001145916,0.0003810199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.636748,0.001385027,0.04439665,0.001559365,0.0008670007,0.00002188833,0.00984852,0.000007456531,0.006964324,0.0005374284,0.01170994,0.2859544],"study_design_scores_gemma":[0.7687505,0.03724518,0.04190467,0.004076856,0.001112067,0.0001103313,0.0152621,0.001334185,0.1017622,0.0007805235,0.02611313,0.001548267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994764,0.0001722469,0.0003242006,0.000483614,0.0007022278,0.002314281,0.00001940126,0.00004699764,0.001173037],"genre_scores_gemma":[0.9942533,0.001014532,0.0009905712,0.0002573809,0.001313498,0.0004464961,0.00008259404,0.00007205216,0.001569592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2844061,"threshold_uncertainty_score":0.6460573,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093592416","doi":"10.1016/j.leukres.2005.06.011","title":"Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology","year":2005,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; World Health Organization","keywords":"Myelodysplastic syndromes; Haematopoiesis; Leukemia; Bone marrow; Stem cell; Preleukemia; Disease; Immunology; Hematology; Pathogenesis; Cancer research; Acute leukemia; Medicine; Biology; Pathology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1440296921385459,"gpt":0.5130137743359242,"spread":0.3689840821973783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00251843,0.0008299164,0.003177748,0.002656455,0.0004221584,0.00007350096,0.001673868,0.001208802,0.0001449174],"category_scores_gemma":[0.002950625,0.0006375325,0.00109708,0.003174649,0.0008163146,0.0001127466,0.001208144,0.002243274,0.0006624178],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01066632,"about_ca_system_score_gemma":0.0255802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004572886,"about_ca_topic_score_gemma":0.000009565991,"domain_scores_codex":[0.9924465,0.0007221476,0.001636089,0.001789807,0.001188385,0.002217003],"domain_scores_gemma":[0.9899592,0.003282704,0.0003839506,0.002560622,0.001862705,0.001950786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007601683,0.0002093286,0.00004660443,0.0197371,0.0005889239,0.00005300377,0.00004022423,0.000002137184,0.0002295401,0.002434994,0.02651629,0.9493817],"study_design_scores_gemma":[0.001822448,0.001249198,0.0001348734,0.01267829,0.001367427,0.0001770022,0.00001350918,0.0001390257,0.00004641433,0.0003877042,0.9814858,0.0004982399],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001477365,0.9796548,0.001240875,0.002376053,0.0001502067,0.01325584,0.001698158,0.0001524498,0.001323819],"genre_scores_gemma":[0.0002181622,0.9754366,0.007260063,0.0001193311,0.001253918,0.00912183,0.002026844,0.0003211808,0.004242107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9549696,"threshold_uncertainty_score":0.9996076,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966423882","doi":"10.1016/j.leukres.2008.06.027","title":"Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Research; State Key Laboratory of Polymer Physics and Chemistry; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Plasma cell leukemia; Leukemia; Chromosome; Cancer research; Biology; Genetics; Medicine; Immunology; Bone marrow; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1218959362799102,"gpt":0.4022160662119751,"spread":0.2803201299320649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002215039,0.0003160304,0.0008068977,0.0006838505,0.0006524834,0.00005564394,0.0004924054,0.0005006716,0.0002580647],"category_scores_gemma":[0.001443013,0.0002808493,0.0002276148,0.001012244,0.002537325,0.0002096643,0.0007889236,0.001929414,0.00013644],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01816541,"about_ca_system_score_gemma":0.03232258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003806245,"about_ca_topic_score_gemma":0.000233609,"domain_scores_codex":[0.9941303,0.0006040899,0.00104243,0.0008007861,0.002192785,0.001229617],"domain_scores_gemma":[0.9950913,0.002236668,0.0001101414,0.001054307,0.0008103906,0.0006971904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01268562,0.00356897,0.2411209,0.01581121,0.003130563,0.02207814,0.03913876,0.0017337,0.2132115,0.008035101,0.3790663,0.06041916],"study_design_scores_gemma":[0.1057778,0.007707032,0.5045844,0.001817202,0.0004509751,0.01810663,0.006612036,0.0841457,0.227464,0.001314496,0.03985685,0.002162872],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674746,0.00174006,0.00002184314,0.0002456132,0.0001339143,0.0008836304,0.0000218375,0.00007924343,0.02939923],"genre_scores_gemma":[0.9808255,0.004493257,0.002338311,0.00009161717,0.0006238089,0.00007977214,0.00002852738,0.00007796156,0.01144119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3392095,"threshold_uncertainty_score":0.9999644,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039249445","doi":"10.1016/j.leukres.2006.06.001","title":"CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Myeloid leukemia; Internal medicine; Karyotype; Medicine; Gastroenterology; Leukemia; Multivariate analysis; CD34; Myeloid; Complete remission; Oncology; Chemotherapy; Biology; Chromosome; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.01521012078207623,"gpt":0.2828162813017182,"spread":0.267606160519642,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002089766,0.0005753895,0.000789081,0.00102074,0.0005029987,0.0001940043,0.0006123049,0.0004472594,0.0001420312],"category_scores_gemma":[0.001033917,0.0004419887,0.00008403106,0.00121196,0.0008942755,0.0006330193,0.00145477,0.002355421,0.00004219216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003221392,"about_ca_system_score_gemma":0.00390342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003802891,"about_ca_topic_score_gemma":0.0003782878,"domain_scores_codex":[0.9919076,0.0007239538,0.0006750245,0.001373822,0.003495602,0.001823991],"domain_scores_gemma":[0.9954842,0.000735097,0.0001201642,0.001241141,0.001005754,0.001413642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02805655,0.0004772488,0.9292082,0.0006787351,0.0001268431,0.00186599,0.0002641433,0.00004994968,0.02252321,0.0003182598,0.01011575,0.006315134],"study_design_scores_gemma":[0.01950142,0.001400227,0.9717765,0.000626187,0.00007666575,0.00003507834,0.0002158075,0.001659987,0.002699828,0.0002741321,0.001245345,0.0004888523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915897,0.0005992029,0.00003042362,0.001496878,0.0001200625,0.001901069,0.0002108904,0.0001268422,0.003924912],"genre_scores_gemma":[0.9932964,0.0003748616,0.0008346259,0.0001138512,0.0004283132,0.000125344,0.0006519158,0.000153403,0.004021292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04256828,"threshold_uncertainty_score":0.9999462,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081434852","doi":"10.1016/j.leukres.2013.06.020","title":"t(11;14) multiple myeloma: A subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Bortezomib; Cohort; Internal medicine; CD20; Incidence (geometry); Medicine; Plasma cell leukemia; Population; Oncology; Immunology; Gastroenterology; Lymphoma","retraction":null,"screen_n_in":null,"score":{"opus":0.06183816214560683,"gpt":0.3298093124874406,"spread":0.2679711503418337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009645765,0.0004652037,0.0008138101,0.0003825496,0.0006950911,0.0002232393,0.0005571492,0.0004202547,0.001604022],"category_scores_gemma":[0.005176893,0.000306892,0.0001899823,0.0008771218,0.0006708432,0.0002428342,0.0005661593,0.00196081,0.001845821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002756686,"about_ca_system_score_gemma":0.0008473005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005532241,"about_ca_topic_score_gemma":0.0004576856,"domain_scores_codex":[0.9940451,0.0005817317,0.0005893456,0.0008159764,0.002082169,0.001885609],"domain_scores_gemma":[0.9954864,0.001201618,0.0001493496,0.001051265,0.001371878,0.0007394642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002224188,0.0009509717,0.9696213,0.0001154396,0.0006528175,0.001380219,0.0001472294,0.000001033515,0.009898948,0.0001365953,0.002151825,0.01271944],"study_design_scores_gemma":[0.007298087,0.001289684,0.9876652,0.0001624109,0.00005852176,0.00008514186,0.0001640935,0.0005480827,0.001074255,0.00007769779,0.001259256,0.0003175636],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942372,0.0005322257,0.00002712631,0.0008338765,0.0001347047,0.00221588,0.0001275186,0.0002047243,0.001686741],"genre_scores_gemma":[0.9801143,0.0001182452,0.0004016852,0.00008222323,0.0001617478,0.0006042485,0.0008567703,0.00008573938,0.01757501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01804391,"threshold_uncertainty_score":0.9999383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041790656","doi":"10.1016/j.leukres.2005.07.008","title":"Analysis of PTEN deletions and mutations in multiple myeloma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; Plasma cell leukemia; Cancer research; Multiple myeloma; Biology; Tumor suppressor gene; Pathogenesis; Plasma cell; Molecular biology; Mutation; Gene; Genetics; Immunology; Carcinogenesis; Apoptosis; PI3K/AKT/mTOR pathway","retraction":null,"screen_n_in":null,"score":{"opus":0.04689792716890501,"gpt":0.3650777894425504,"spread":0.3181798622736454,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004968803,0.00006374603,0.0001255063,0.0003688144,0.00006892906,0.00001374316,0.0001514551,0.0001059284,0.00004825681],"category_scores_gemma":[0.0002926032,0.0000657002,0.00005486506,0.0007781134,0.0001860279,0.000003973278,0.00009929519,0.0001594024,0.00000617663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001381853,"about_ca_system_score_gemma":0.0002249294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000373993,"about_ca_topic_score_gemma":0.002604456,"domain_scores_codex":[0.9990028,0.0001112698,0.0001801872,0.0002513162,0.0002183904,0.0002361022],"domain_scores_gemma":[0.9993663,0.0001035827,0.00002927696,0.0002702265,0.0001689281,0.00006164204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008843366,0.00006769775,0.1021377,0.0000201998,0.0003163837,0.000004351291,0.00030999,0.01802096,0.8614881,0.0001533739,0.000903269,0.01648951],"study_design_scores_gemma":[0.002404497,0.0003274185,0.3435938,0.00004510549,0.0001844161,0.000007816522,0.0005823854,0.1047874,0.5094533,0.0001876728,0.03801678,0.0004093571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976649,0.0006563563,0.0004149839,0.000227129,0.00001088936,0.0001058391,0.00003306055,0.00000428294,0.0008825454],"genre_scores_gemma":[0.9981614,0.0001307502,0.001019715,0.00003776261,0.00007171083,0.00004368312,0.00009521296,0.000009808295,0.0004299415],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3520348,"threshold_uncertainty_score":0.2679177,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062572127","doi":"10.1016/j.leukres.2015.01.013","title":"Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada; University of Ottawa; Atomic Energy (Canada); Ottawa Hospital","funders":"Canadian Institutes of Health Research; Canadian Nuclear Laboratories","keywords":"Mesenchymal stem cell; Haematopoiesis; CD34; Bone marrow; Myeloid leukemia; Progenitor cell; Cancer research; Stromal cell; Leukemia; Immunology; Medicine; Myeloid; Biology; Stem cell; Pathology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.07850938879730575,"gpt":0.3334496553550783,"spread":0.2549402665577726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001464779,0.0006293821,0.001024016,0.0007783262,0.0003640449,0.000295569,0.0009122586,0.0004535542,0.0005028127],"category_scores_gemma":[0.0006078219,0.0004782312,0.0001833629,0.001345586,0.0005605663,0.000284808,0.0008430944,0.002164811,0.001262056],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005836832,"about_ca_system_score_gemma":0.003426245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005243039,"about_ca_topic_score_gemma":0.0003865894,"domain_scores_codex":[0.9886896,0.0008631233,0.000767905,0.001485487,0.005858344,0.002335522],"domain_scores_gemma":[0.9926477,0.0004871041,0.0001353663,0.001590918,0.002240814,0.00289808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02328193,0.002089937,0.4756401,0.0007989781,0.002465996,0.002593406,0.01328229,0.0001598607,0.4126115,0.0001391623,0.06292403,0.004012755],"study_design_scores_gemma":[0.0299754,0.009912577,0.2347762,0.00103346,0.0003903661,0.0001192456,0.00294791,0.003218734,0.7107893,0.0005346427,0.004567896,0.001734304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917397,0.00007438334,0.0001365883,0.0002811906,0.000254035,0.003626674,0.0001864981,0.0001550799,0.00354584],"genre_scores_gemma":[0.9912487,0.00001243011,0.001869494,0.00007828373,0.0006198371,0.0003801268,0.0003075275,0.0001602035,0.005323431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2981777,"threshold_uncertainty_score":0.9997669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125735390","doi":"10.1016/j.leukres.2009.07.043","title":"Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; McGill University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Daunorubicin; Etoposide; Leukemia; Cytotoxic T cell; Cytarabine; Cancer research; Chemistry; Pharmacology; Biology; In vitro; Biochemistry; Immunology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.03392273483800691,"gpt":0.3413022919662653,"spread":0.3073795571282584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436749,0.0001589147,0.0002225508,0.0003498397,0.00006046526,0.00002415025,0.0002028249,0.0002367003,0.000008106203],"category_scores_gemma":[0.0001296163,0.000152497,0.00004235055,0.0006296251,0.00009272336,0.00001554135,0.00003147624,0.0003787214,0.00000509218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000937901,"about_ca_system_score_gemma":0.0005199771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001963534,"about_ca_topic_score_gemma":0.0001742107,"domain_scores_codex":[0.9978617,0.0004844371,0.0003501259,0.000387714,0.0004932398,0.0004227884],"domain_scores_gemma":[0.9993078,0.0001496128,0.0001001673,0.0002459154,0.0001407383,0.00005583856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00068902,0.00004523835,0.002790047,0.00007619149,0.00001626624,0.00004081906,0.0002054181,0.006015356,0.9833683,0.00002358485,0.00004509843,0.006684642],"study_design_scores_gemma":[0.003145633,0.00207867,0.009269828,0.0001950549,0.00001102921,0.000004826902,0.00002447205,0.003900605,0.9810593,0.00011664,0.00003504162,0.0001589532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977355,0.0001784846,0.0005670892,0.00004091912,0.00003550505,0.0005984051,0.000009376085,0.000009548028,0.0008251603],"genre_scores_gemma":[0.9993116,0.00009053858,0.0002301425,0.00003472139,0.00005670884,0.00005901559,0.0001481713,0.00002308624,0.00004597601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006525689,"threshold_uncertainty_score":0.6218647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036563645","doi":"10.1016/j.leukres.2007.09.015","title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Efflux; Western blot; Multiple drug resistance; Transporter; Cell culture; Pharmacology; Cell biology; Biology; Chemistry; Drug resistance; Biochemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02607650836429251,"gpt":0.3303058641209038,"spread":0.3042293557566114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003058585,0.000263183,0.0006534902,0.001595602,0.0001102555,0.00001896645,0.0002978042,0.0002659376,0.000115812],"category_scores_gemma":[0.0001712252,0.0002302648,0.00006876227,0.002180997,0.0007689929,0.0002096622,0.0001069951,0.0004549474,0.000008937593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003242533,"about_ca_system_score_gemma":0.001452847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001357099,"about_ca_topic_score_gemma":0.00147571,"domain_scores_codex":[0.9952403,0.0001696576,0.0009753862,0.0006341573,0.002080749,0.000899729],"domain_scores_gemma":[0.9973558,0.0005215181,0.0001749597,0.0007450064,0.0008094689,0.0003933059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006016474,0.0001082232,0.01502403,0.0008729833,0.0000581521,0.00005968784,0.002173578,0.0007928445,0.9707069,0.001022369,0.0007036438,0.002461112],"study_design_scores_gemma":[0.007738726,0.0008547929,0.3722458,0.0008880752,0.00003124691,0.00001838778,0.0007631471,0.0008693513,0.6157927,0.0003506654,0.000240192,0.0002069647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994124,0.0001042685,0.001043363,0.0002871291,0.00003134397,0.001578401,0.00001550957,0.00002929343,0.002786716],"genre_scores_gemma":[0.9936591,0.00002560551,0.001834691,0.00003872029,0.00009041704,0.00004340648,0.00005858249,0.00005915906,0.004190322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3572217,"threshold_uncertainty_score":0.9389926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981161460","doi":"10.1016/j.leukres.2009.01.010","title":"p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Intramedullary rod; Multiple myeloma; Bone marrow; Medicine; Pathology; Medullary cavity; Proliferation index; Plasmacytoma; Immunohistochemistry; Internal medicine; Anatomy","retraction":null,"screen_n_in":null,"score":{"opus":0.09732688832183028,"gpt":0.4157256430816742,"spread":0.3183987547598439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008227453,0.0001903214,0.0003783699,0.0004115053,0.0002385793,0.000045821,0.0002039933,0.000226964,0.0002907045],"category_scores_gemma":[0.001128335,0.0001363018,0.0000963175,0.0009361603,0.0002422055,0.0001712662,0.0000751467,0.0007081982,0.00009675275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009174683,"about_ca_system_score_gemma":0.0006510753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001455079,"about_ca_topic_score_gemma":0.0000222294,"domain_scores_codex":[0.9961923,0.0002573418,0.0003156062,0.000436926,0.002015584,0.0007822856],"domain_scores_gemma":[0.9977831,0.0004014876,0.00009778584,0.000548235,0.0007741348,0.0003952613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01468513,0.003214345,0.3451746,0.0003478794,0.0007273488,0.002131912,0.002238742,0.00004878818,0.1311657,0.0004477188,0.009212678,0.4906052],"study_design_scores_gemma":[0.01088693,0.005161823,0.9259557,0.00100431,0.00004314158,0.00006104872,0.0002365564,0.02139848,0.03341566,0.000245131,0.001380251,0.0002110387],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992663,0.0001924405,0.00001881196,0.001087054,0.00001447348,0.001191899,0.00001918615,0.00009009276,0.004723061],"genre_scores_gemma":[0.9968386,0.00007247283,0.001614104,0.0001131136,0.00006675784,0.00002998083,0.0001346173,0.00003917708,0.001091183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.580781,"threshold_uncertainty_score":0.5558226,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2066443904","doi":"10.1016/j.leukres.2009.02.010","title":"Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: A retrospective study of 322 bone marrows","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; Anemia; Pediatrics; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.027599261148579,"gpt":0.3292965464634623,"spread":0.3016972853148834,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002985538,0.0002661796,0.0007859349,0.0007977774,0.0001819196,0.00003030975,0.0006910375,0.0001330846,0.0001158326],"category_scores_gemma":[0.002836894,0.0001698605,0.0000658979,0.002663444,0.0005153663,0.0001982794,0.0002982665,0.001660745,0.00001641964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002398233,"about_ca_system_score_gemma":0.00143539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006451103,"about_ca_topic_score_gemma":0.0001031065,"domain_scores_codex":[0.9939913,0.0006901686,0.000783159,0.0006579634,0.003005872,0.0008715641],"domain_scores_gemma":[0.9963698,0.0007902035,0.0002292918,0.001143464,0.001283097,0.0001841795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006938817,0.002163704,0.9769186,0.001092698,0.0001614614,0.000352648,0.006217782,0.0008115885,0.002173038,0.0001596457,0.0003717626,0.002638234],"study_design_scores_gemma":[0.01062105,0.01077289,0.9700168,0.0008188998,0.00006044416,0.00002792764,0.001443451,0.005394,0.0005442901,0.0001451443,0.000004182225,0.0001508729],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994954,0.00008669701,0.00002881459,0.0003597369,0.00002495191,0.003468268,0.00001814947,0.00002688488,0.00103249],"genre_scores_gemma":[0.9976841,0.00001403652,0.00113028,0.00002520656,0.00004531297,0.0001262287,0.000008372312,0.00003922113,0.000927195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008609182,"threshold_uncertainty_score":0.7215204,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050306927","doi":"10.1016/j.leukres.2006.10.023","title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Celgene","keywords":"Myelodysplastic syndromes; Lenalidomide; Chromosomal Abnormality; Abnormality; Medicine; Cytogenetics; Disease; Chromosome abnormality; Oncology; Internal medicine; Karyotype; Chromosome; Bone marrow; Biology; Multiple myeloma; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.3313275746400015,"gpt":0.4931080361080982,"spread":0.1617804614680967,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01226308,0.0004829716,0.002377155,0.002102534,0.0001052553,0.00003658526,0.0007771729,0.0005225491,0.000154888],"category_scores_gemma":[0.001333072,0.0002980154,0.0005731664,0.002527084,0.000675604,0.00006435444,0.0001382898,0.001220124,0.00006747044],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01178236,"about_ca_system_score_gemma":0.01368364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002505414,"about_ca_topic_score_gemma":0.0002265477,"domain_scores_codex":[0.9859788,0.004875132,0.001576352,0.0006731182,0.005878155,0.001018427],"domain_scores_gemma":[0.9929319,0.003680331,0.0003486001,0.001432971,0.001482605,0.0001235865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008729037,0.0004711579,0.0001360166,0.02474982,0.0004374168,0.0001999335,0.0008678214,0.00008211136,0.00001045099,0.000180303,0.0006429374,0.9721348],"study_design_scores_gemma":[0.008033969,0.005859946,0.001578674,0.04561968,0.005861143,0.001159262,0.001478252,0.002400873,0.000285948,0.0005781491,0.9264126,0.0007315013],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01923737,0.9689324,0.000002606404,0.00003545111,0.00006351789,0.004838123,0.00007019866,0.00001378168,0.006806526],"genre_scores_gemma":[0.01058175,0.9864014,0.0001143829,0.000002922059,0.0002373012,0.001388695,0.0002232765,0.00008678798,0.0009635076],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9714032,"threshold_uncertainty_score":0.9999472,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035278640","doi":"10.1016/j.leukres.2014.10.005","title":"Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Bosutinib; Ponatinib; Nilotinib; Dasatinib; Medicine; Tyrosine kinase; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib; Pharmacology; Oncology; Leukemia; Myeloid leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.08836413084802916,"gpt":0.4135965523823236,"spread":0.3252324215342944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003491497,0.001580492,0.005369623,0.001649889,0.00034913,0.0001043709,0.00106534,0.001395607,0.0003146699],"category_scores_gemma":[0.00077469,0.001100924,0.001452573,0.002310574,0.001035298,0.000230341,0.0004228574,0.002639857,0.0001122612],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03627658,"about_ca_system_score_gemma":0.02130654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006584024,"about_ca_topic_score_gemma":0.002502901,"domain_scores_codex":[0.9887324,0.001952921,0.003322067,0.001889193,0.002191979,0.001911416],"domain_scores_gemma":[0.9917842,0.002580109,0.001494378,0.002635148,0.001059129,0.0004470449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004896398,0.006928454,0.0001044917,0.1351887,0.004287227,0.001188194,0.005276904,0.0003728036,0.02325279,0.0002806067,0.04418049,0.7740429],"study_design_scores_gemma":[0.07064252,0.0203864,0.0002344443,0.05183573,0.004896413,0.0003943476,0.0003128181,0.002536115,0.04235895,0.00003715791,0.8045246,0.00184049],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1323287,0.8519613,0.00003117705,0.0001557644,0.0003218133,0.01363826,0.001289116,0.0000646295,0.0002092911],"genre_scores_gemma":[0.2975844,0.6751514,0.001117074,0.0000901774,0.005692121,0.007360357,0.009967854,0.0005011042,0.002535508],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7722024,"threshold_uncertainty_score":0.9999008,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092340195","doi":"10.1016/j.leukres.2012.03.001","title":"Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institutes of Health","keywords":"EZH2; PRC2; Biology; DNA methylation; Epigenetics; Histone methyltransferase; Cancer research; Histone methylation; Cancer epigenetics; Gene silencing; Molecular biology; Methylation; Carcinogenesis; Histone H3; Epigenetic therapy; Histone; Gene expression; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05787510951991737,"gpt":0.3848753231151511,"spread":0.3270002135952337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001786505,0.00009576061,0.0001923097,0.0002805522,0.00005312552,0.000004838485,0.00008575687,0.0002016993,0.000008479366],"category_scores_gemma":[0.0005585025,0.000098029,0.00005430283,0.0003253674,0.000217802,0.00001870062,0.00007847216,0.0001260715,9.061743e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001266766,"about_ca_system_score_gemma":0.0001586444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002256843,"about_ca_topic_score_gemma":0.00001591669,"domain_scores_codex":[0.9984444,0.000313828,0.0004218461,0.0001861546,0.0004260323,0.0002076788],"domain_scores_gemma":[0.9987677,0.0001384949,0.0002761786,0.0002482815,0.0005028461,0.00006654902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009688039,0.00007067955,0.006787525,0.0001541994,0.00002840686,6.210638e-8,0.0002223494,0.00009880582,0.9814157,0.0006718459,0.00003786266,0.01041572],"study_design_scores_gemma":[0.0004976164,0.000301751,0.0368768,0.00002954058,0.00002131799,4.255378e-7,0.0001139173,0.0006088965,0.9605732,0.0005480797,0.0003509152,0.00007756233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931223,0.003277637,0.002674602,0.00001796008,0.00010956,0.0002273169,0.000009470257,0.000003667668,0.0005574963],"genre_scores_gemma":[0.9984732,0.000627284,0.0005575182,0.000001555125,0.00009348994,0.00001105631,0.0001002908,0.00001620352,0.0001193929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03008928,"threshold_uncertainty_score":0.3997506,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048159897","doi":"10.1016/j.leukres.2009.07.006","title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"North York General Hospital","funders":"","keywords":"Karyotype; International Prognostic Scoring System; Cytogenetics; Myelodysplastic syndromes; Medicine; Internal medicine; Biology; Chromosome; Genetics; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.1295770373685504,"gpt":0.4778804330612476,"spread":0.3483033956926971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004277027,0.000233098,0.000468051,0.001104972,0.0002377512,0.0002594735,0.0003778889,0.00009319233,0.00005747111],"category_scores_gemma":[0.001788916,0.0001944605,0.00004394331,0.000658997,0.0000683993,0.0005533763,0.0001559647,0.000388665,0.00000295152],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003965461,"about_ca_system_score_gemma":0.00110291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004695224,"about_ca_topic_score_gemma":0.0001086821,"domain_scores_codex":[0.9944551,0.0004529567,0.0006932928,0.0006165051,0.003290125,0.0004920489],"domain_scores_gemma":[0.9958501,0.0006364429,0.0004160833,0.0004448891,0.002415508,0.0002369451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06582531,0.004850728,0.764051,0.01053453,0.003874338,0.0002638164,0.02800009,0.002473543,0.05390842,0.0008116883,0.0004686962,0.06493789],"study_design_scores_gemma":[0.05577839,0.05136977,0.6596779,0.01116062,0.001239282,0.0001816879,0.04094972,0.1701406,0.008039128,0.0003568516,0.0001576077,0.0009484685],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901661,0.00001712251,0.001012884,0.0004710138,0.0001614666,0.007984582,0.00004943616,0.00002520648,0.0001121846],"genre_scores_gemma":[0.9921789,0.00001292289,0.00698181,0.0001144668,0.0001434439,0.0003418672,0.0001476977,0.0000444734,0.00003441444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1676671,"threshold_uncertainty_score":0.9998581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2576905928","doi":"10.1016/j.leukres.2017.01.005","title":"Current approach to the treatment of chronic myeloid leukaemia","year":2017,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Ponatinib; Hematologist; Imatinib; Intensive care medicine; Imatinib mesylate; Chronic myeloid leukaemia; Oncology; Myeloid leukemia; Immunology; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.3100638100786055,"gpt":0.4895030462241493,"spread":0.1794392361455439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001637941,0.001053026,0.003995199,0.0009668755,0.0006612171,0.0001439645,0.001921846,0.0006884836,0.0001525807],"category_scores_gemma":[0.0004355614,0.0005875024,0.001537236,0.001079363,0.0006772351,0.00007932051,0.0005459889,0.002012247,0.001965686],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05763966,"about_ca_system_score_gemma":0.02792252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008714272,"about_ca_topic_score_gemma":0.00008285061,"domain_scores_codex":[0.9922735,0.0008040612,0.001300354,0.001575885,0.002313876,0.001732295],"domain_scores_gemma":[0.9919732,0.000800959,0.000545453,0.005482792,0.0004730968,0.0007244522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007333628,0.0009233738,0.000008499434,0.02035229,0.0008387598,0.00007051055,0.000305281,0.00000599413,0.000001133801,0.0001682239,0.0113774,0.9658752],"study_design_scores_gemma":[0.002548854,0.002048567,0.00003126239,0.01473195,0.001361241,0.0002368662,0.00002730112,0.0001004487,0.00002184709,0.00001304146,0.9784803,0.000398297],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008228351,0.9748484,0.00001789159,0.0001167743,0.0005046924,0.008701473,0.0001584573,0.00006831779,0.01550165],"genre_scores_gemma":[0.00009183008,0.9798663,0.0002120274,0.000008686356,0.002498755,0.003643146,0.0006028092,0.0002203871,0.01285602],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9671029,"threshold_uncertainty_score":0.9996576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095086994","doi":"10.1016/s0145-2126(02)00002-4","title":"Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"CTL*; Dendritic cell; CD86; Immune system; Priming (agriculture); CD40; Biology; Cell fusion; Immunology; CD80; Immunotherapy; Immunity; Cytotoxic T cell; T cell; In vitro; Cell culture; CD8","retraction":null,"screen_n_in":null,"score":{"opus":0.02628098346899559,"gpt":0.2836075055417486,"spread":0.257326522072753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009418784,0.000238289,0.0004516301,0.0004035515,0.0004710424,0.00003000319,0.0004272812,0.0002952363,0.0008652161],"category_scores_gemma":[0.0002874789,0.0002062244,0.0000997883,0.0004078928,0.0004401145,0.000239915,0.0002230579,0.001260677,0.0003028677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001554131,"about_ca_system_score_gemma":0.0001115341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000228145,"about_ca_topic_score_gemma":0.00000858358,"domain_scores_codex":[0.9973524,0.001061761,0.0004274336,0.0003582281,0.0001450524,0.0006550816],"domain_scores_gemma":[0.9980382,0.0009994517,0.000104211,0.0005586793,0.0002636368,0.00003586219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009740024,0.0001123467,0.00003686066,0.0000780274,0.0001673899,0.00002851303,0.0009801739,0.000007355273,0.9915829,0.0004063006,0.001908026,0.003718137],"study_design_scores_gemma":[0.002248644,0.0005263955,0.004754837,0.0001299082,0.00001903038,0.0001584586,0.0003028009,0.0001175278,0.9849246,0.0001726626,0.006433967,0.0002112138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9609913,0.03704479,0.00009786881,0.0001994655,0.0002790662,0.0003828758,0.00006280041,0.0000478581,0.0008939293],"genre_scores_gemma":[0.9814118,0.007254533,0.000146379,0.00003449891,0.00002680339,0.0000277858,0.00004511035,0.00002959877,0.01102352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02979026,"threshold_uncertainty_score":0.9473509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017848739","doi":"10.1016/j.leukres.2009.06.013","title":"High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"Microsoft","keywords":"Cancer registry; Chronic lymphocytic leukemia; Medicine; Immunophenotyping; Incidence (geometry); Population; Epidemiology; Cohort; Relative survival; Internal medicine; Lymphoma; Leukemia; Oncology; Immunology; Flow cytometry; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02041312935278395,"gpt":0.3231143582226167,"spread":0.3027012288698328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003002643,0.0005320627,0.001099649,0.001508827,0.0005597529,0.0001328459,0.001172516,0.0006529852,0.0009180915],"category_scores_gemma":[0.002576764,0.0005219788,0.0002750789,0.00279215,0.0006142312,0.0002749511,0.0001656035,0.001576378,0.0004011228],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.5172555,"about_ca_system_score_gemma":0.2707443,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8153822,"about_ca_topic_score_gemma":0.05311855,"domain_scores_codex":[0.9911073,0.0005265023,0.001166495,0.001198053,0.003443694,0.002557997],"domain_scores_gemma":[0.9935229,0.001438231,0.0002123087,0.002130482,0.001223956,0.001472113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01380057,0.001645269,0.1306313,0.007965195,0.002570615,0.01531247,0.00276063,0.125856,0.2475393,0.02021837,0.2769267,0.1547736],"study_design_scores_gemma":[0.0772601,0.00574741,0.2705241,0.003462142,0.0003024272,0.0005143275,0.000299208,0.552945,0.07402637,0.002552984,0.01021547,0.002150505],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909063,0.002508151,0.0001088145,0.0007077185,0.0001770477,0.002399423,0.00007348404,0.0001608963,0.00295814],"genre_scores_gemma":[0.9951968,0.0003621336,0.0004561148,0.0006165345,0.0003606332,0.0002092613,0.0005902511,0.0001111099,0.002097162],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7622636,"threshold_uncertainty_score":0.9999952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127147516","doi":"10.1016/j.leukres.2008.02.021","title":"Iron overload in myelodysplastic syndromes: A Canadian consensus guideline","year":2008,"lang":"en","type":"editorial","venue":"Leukemia Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; BC Cancer Agency; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; McMaster University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Diamond Blackfan Anemia Foundation","keywords":"Guideline; Medicine; Myelodysplastic syndromes; Clinical Practice; Intensive care medicine; Expert opinion; Mandate; Family medicine; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0399239366646835,"gpt":0.3649555244959128,"spread":0.3250315878312293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001980412,0.0005131118,0.001099539,0.002585054,0.0002605813,0.00006187477,0.0005274631,0.001961198,0.0007159336],"category_scores_gemma":[0.01074496,0.0004899003,0.0001727883,0.001281854,0.0005975324,0.00004637343,0.0001612855,0.005138647,0.001211279],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005670062,"about_ca_system_score_gemma":0.04268432,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5492942,"about_ca_topic_score_gemma":0.2492082,"domain_scores_codex":[0.9924401,0.0004255146,0.0009494781,0.001014737,0.003160665,0.002009478],"domain_scores_gemma":[0.9949163,0.001708928,0.0001037425,0.001080285,0.001031933,0.001158811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004178373,0.00005561968,0.0001800602,0.0005952381,0.00002037038,0.005862685,0.0002072323,0.0000371254,0.00003704374,0.00003310696,0.9916157,0.0009379493],"study_design_scores_gemma":[0.005033422,0.0002799627,0.00063195,0.0004874958,0.0000529474,0.0001330388,0.0003316221,0.0001501793,0.00000622017,0.00006380177,0.992411,0.0004184188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.04406416,0.01214487,0.000004292195,0.002783877,0.861703,0.00300065,0.001057649,0.0001570393,0.07508445],"genre_scores_gemma":[0.0146282,0.009616118,0.0007984434,0.000481446,0.9084174,0.000270699,0.004205245,0.000386152,0.06119632],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.3000859,"threshold_uncertainty_score":0.9997553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964125608","doi":"10.1016/j.leukres.2012.11.013","title":"Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research; Ministerul Cercetării, Inovării şi Digitalizării","keywords":"Myeloid leukemia; Cancer-related fatigue; Medicine; Cytokine; Tumor necrosis factor alpha; Internal medicine; Chemokine; Myeloid; Oncology; Leukemia; Immunology; Cancer; Gastroenterology; Inflammation","retraction":null,"screen_n_in":null,"score":{"opus":0.1157119307328995,"gpt":0.3813353205692868,"spread":0.2656233898363873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004324647,0.0002740949,0.0008462984,0.001168603,0.0001007949,0.00003172582,0.0001767137,0.0003613627,0.00005132139],"category_scores_gemma":[0.001217904,0.0002253727,0.00003067752,0.001417778,0.0006052307,0.0003948776,0.0003927697,0.001622404,0.00001103986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002956192,"about_ca_system_score_gemma":0.001417134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003857291,"about_ca_topic_score_gemma":0.0008797384,"domain_scores_codex":[0.9954047,0.0007110441,0.0006676308,0.0005330713,0.001556324,0.001127283],"domain_scores_gemma":[0.9972242,0.001125402,0.0001198815,0.0005158865,0.0004293386,0.0005852945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001635154,0.00009288896,0.9891608,0.0003853287,0.00008395312,0.0000135876,0.001398879,0.00001010526,0.001986259,0.0002030575,0.000124235,0.00490575],"study_design_scores_gemma":[0.01004133,0.0006501059,0.9859615,0.0002896097,0.00002435525,0.000005197088,0.0003517845,0.0003775223,0.001903571,0.00004547926,0.0001367334,0.0002127816],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966747,0.0003579237,0.00008023207,0.0005976983,0.00002453225,0.001399864,0.00008223724,0.00002305583,0.0007597671],"genre_scores_gemma":[0.9984159,0.0002020662,0.0005921334,0.00007477584,0.0001491571,0.00008447673,0.0001245125,0.00005291812,0.0003040729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00840618,"threshold_uncertainty_score":0.9190431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2488647697","doi":"10.1016/j.leukres.2016.07.004","title":"A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Regimen; Tolerability; Internal medicine; Refractory (planetary science); Gastroenterology; Phases of clinical research; Adverse effect; Surgery; Clinical trial; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05038255470315886,"gpt":0.3669708376196864,"spread":0.3165882829165275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002766046,0.0005311484,0.001025053,0.001080029,0.0004267708,0.00007120229,0.001346305,0.0005031613,0.0003038565],"category_scores_gemma":[0.0005891103,0.0002834749,0.0002968214,0.002220961,0.001402072,0.0003527651,0.0009120905,0.002406596,0.0001712015],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01374148,"about_ca_system_score_gemma":0.007502311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001059742,"about_ca_topic_score_gemma":0.0003307558,"domain_scores_codex":[0.9909375,0.0008097442,0.001158776,0.001145284,0.004003928,0.001944773],"domain_scores_gemma":[0.9947959,0.0006358171,0.0003271788,0.002240106,0.001389462,0.0006116066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6011268,0.009443798,0.03982377,0.0006787429,0.001095317,0.0007618985,0.002548934,0.00000615702,0.2224881,0.0008219584,0.03578683,0.08541764],"study_design_scores_gemma":[0.8265563,0.02773912,0.02620374,0.001841985,0.0002024306,0.00004238317,0.0002432865,0.00006114173,0.09369332,0.0002563181,0.02235777,0.0008021697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904112,0.00009790483,0.00001258232,0.001089682,0.0003007763,0.005224436,0.0001259572,0.00006606423,0.00267135],"genre_scores_gemma":[0.9915875,0.0001058755,0.0001590013,0.00007976078,0.0005936485,0.0005106194,0.00007531887,0.000139766,0.006748578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2254295,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108145697","doi":"10.1016/j.leukres.2010.05.029","title":"p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; CancerCare Manitoba; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dasatinib; Autophagy; Chronic lymphocytic leukemia; Cancer research; Endoplasmic reticulum; Medicine; Leukemia; Cytotoxic T cell; Immunology; In vitro; Apoptosis; Biology; Imatinib; Cell biology; Myeloid leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.03032644712037905,"gpt":0.3615244237272269,"spread":0.3311979766068479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004340548,0.000297641,0.0006628303,0.0009071011,0.0002413495,0.0001507388,0.0005542445,0.0004148675,0.0002705675],"category_scores_gemma":[0.003875854,0.0002709382,0.00007996389,0.001674353,0.0006958524,0.0001852483,0.0007347406,0.002079384,0.000456282],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03138568,"about_ca_system_score_gemma":0.02458066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002078445,"about_ca_topic_score_gemma":0.002762442,"domain_scores_codex":[0.9942998,0.0003096344,0.0006044115,0.001021148,0.002029965,0.001735028],"domain_scores_gemma":[0.9953255,0.001757215,0.00005393731,0.001272516,0.0006182204,0.0009726232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02150202,0.00114957,0.02932001,0.005258465,0.0003670471,0.01390593,0.007943391,0.00005004029,0.6700789,0.03989781,0.1284144,0.08211233],"study_design_scores_gemma":[0.113015,0.001472892,0.3080873,0.001657165,0.00005451245,0.001189886,0.0006116852,0.00664218,0.0926212,0.004427186,0.4687616,0.001459456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624088,0.001142452,0.00002363052,0.002576883,0.0001597062,0.001662287,0.00002621483,0.0001024451,0.0318976],"genre_scores_gemma":[0.9748155,0.0002921954,0.004996286,0.000877124,0.0004386048,0.0003267925,0.00004198591,0.00008480513,0.01812664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5774577,"threshold_uncertainty_score":0.9999743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991554870","doi":"10.1016/j.leukres.2014.08.008","title":"Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency; Canadian Blood Services; University of Alberta","funders":"University of Alberta; Alberta Innovates; Alberta Innovates - Health Solutions; Canadian Blood Services","keywords":"CD44; Gene silencing; Myeloid leukemia; Cancer research; Stem cell; Leukemia; Jurkat cells; Chemistry; Biology; Cell biology; Cell; Immunology; Biochemistry; Immune system; T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.02026833954695722,"gpt":0.2966030288540788,"spread":0.2763346893071216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009931679,0.0001747296,0.000260437,0.0002234229,0.00007890794,0.00002921976,0.0005253282,0.0002093346,0.00009922472],"category_scores_gemma":[0.0002594858,0.0001706478,0.00009167918,0.0005250371,0.0002248214,0.00001151385,0.0002874808,0.0003763959,0.0002369428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002726591,"about_ca_system_score_gemma":0.0006532709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000895367,"about_ca_topic_score_gemma":0.0001406749,"domain_scores_codex":[0.9976168,0.0003498226,0.0004025717,0.0005021076,0.0004376573,0.0006910153],"domain_scores_gemma":[0.9988504,0.0001161386,0.00008341675,0.0005739288,0.0002227028,0.0001534115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002238344,0.00003171038,0.001582308,0.00002998332,0.00003428205,0.000005740465,0.0001451856,0.0001354888,0.9897524,0.00002058452,0.003562361,0.00447612],"study_design_scores_gemma":[0.0007694813,0.0005559287,0.001177577,0.00005386928,0.000006052461,0.000003845548,0.0002071666,0.0009382747,0.9930469,0.00003201899,0.003023441,0.0001854544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972655,0.0004271813,0.00007531376,0.00008283374,0.0001425605,0.0001947546,0.00001927278,0.00001217707,0.001780362],"genre_scores_gemma":[0.9971949,0.0006688815,0.000197392,0.0001340562,0.0001841551,0.00003968892,0.00006913712,0.00003030855,0.001481486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004290666,"threshold_uncertainty_score":0.6958814,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087111933","doi":"10.1016/j.leukres.2009.09.012","title":"Genetic inactivation of Ikaros is a rare event in human T-ALL","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Biology; Genetics; Allele; Gene; Molecular biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05855812171636873,"gpt":0.4050134406573147,"spread":0.3464553189409459,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00130287,0.000193809,0.0004493558,0.001100412,0.0001002998,0.00002950282,0.0004011,0.0002744271,0.0004046408],"category_scores_gemma":[0.0006372839,0.0001758372,0.0001098997,0.001529345,0.0002378374,0.0001220277,0.0001634051,0.001099752,0.0001020155],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006540276,"about_ca_system_score_gemma":0.002361686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001355193,"about_ca_topic_score_gemma":0.0000418205,"domain_scores_codex":[0.9955791,0.0002898126,0.0006165892,0.0005337503,0.002049992,0.000930751],"domain_scores_gemma":[0.9979523,0.0003082166,0.00008403115,0.0007882996,0.0005769598,0.0002902222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002042818,0.001152004,0.02497643,0.000709234,0.0001239079,0.001217867,0.004445777,0.0002140138,0.8715,0.002048062,0.03669713,0.05487272],"study_design_scores_gemma":[0.01566868,0.004251276,0.609147,0.001106123,0.0000414528,0.0002153913,0.000991398,0.01470704,0.3407128,0.007164322,0.005519939,0.0004745792],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883958,0.000180759,0.0001703521,0.002278768,0.00002232872,0.001052774,0.000007114141,0.00003479704,0.00785735],"genre_scores_gemma":[0.9957432,0.00009690047,0.0007296594,0.0004560362,0.0001623445,0.00006246194,0.00002537598,0.00003406822,0.002689913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5841705,"threshold_uncertainty_score":0.9972734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131671733","doi":"10.1016/j.leukres.2008.01.008","title":"Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lymphoma; Angiogenesis; Medicine; Immunohistochemistry; Carcinogenesis; Epstein–Barr virus; Pathology; Immunology; Virus; Cancer research; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.05021236526045336,"gpt":0.3500590489006126,"spread":0.2998466836401593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005140495,0.0001182903,0.0003177802,0.0002876816,0.0001420917,0.000009516008,0.000132921,0.0001572875,0.00007988633],"category_scores_gemma":[0.0006120477,0.0001031351,0.00004937809,0.000744845,0.0004531791,0.00007475077,0.00009356412,0.0004672305,0.00001825863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006339365,"about_ca_system_score_gemma":0.001406959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001787138,"about_ca_topic_score_gemma":0.00009831964,"domain_scores_codex":[0.9980841,0.0001267297,0.0002652195,0.0003270373,0.0006717946,0.0005251363],"domain_scores_gemma":[0.9989713,0.0003130859,0.00005276781,0.000289859,0.0001850922,0.0001879157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001522743,0.0006371941,0.8034015,0.0007432276,0.00008632416,0.0009290005,0.006325535,0.0001073948,0.1483651,0.0003529767,0.02470057,0.01282848],"study_design_scores_gemma":[0.0134708,0.001327261,0.9540514,0.001139519,0.00003118152,0.00006708129,0.003127787,0.001848937,0.01984926,0.001133468,0.003610991,0.0003423426],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837724,0.00121383,0.00001552116,0.0004879001,0.00003421398,0.0006427883,0.000007336998,0.00002107266,0.01380493],"genre_scores_gemma":[0.9966847,0.001175934,0.0002402382,0.00007936938,0.00005099556,0.0001391685,0.000008463063,0.0000238562,0.001597226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1506499,"threshold_uncertainty_score":0.4205728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3106887103","doi":"10.1016/j.leukres.2020.106489","title":"Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Cytarabine; Medicine; Myeloid leukemia; Adverse effect; Internal medicine; Gastroenterology; Refractory (planetary science); Myeloid; Leukemia; Acute leukemia; Pharmacology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1025090926772272,"gpt":0.3992120490464178,"spread":0.2967029563691906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004084319,0.0008575663,0.001669645,0.001331516,0.0004525695,0.0003083445,0.001055203,0.0006120129,0.0006543692],"category_scores_gemma":[0.001178236,0.0006555492,0.0001636065,0.005329879,0.0007335471,0.001012939,0.0009441306,0.005478249,0.0007711655],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008976076,"about_ca_system_score_gemma":0.008335928,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01655885,"about_ca_topic_score_gemma":0.005191701,"domain_scores_codex":[0.9876144,0.001229678,0.001760193,0.002749795,0.004222773,0.002423181],"domain_scores_gemma":[0.9933717,0.001035507,0.0002638891,0.002158754,0.001138106,0.002032045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.588893,0.01030889,0.006752631,0.0005623139,0.001532575,0.08483642,0.02248514,0.0006919282,0.2128597,0.00007154437,0.05551552,0.01549038],"study_design_scores_gemma":[0.6302657,0.06485773,0.01864246,0.001364002,0.0006100354,0.000770523,0.01554842,0.04521907,0.2047341,0.0001836396,0.01538471,0.002419578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779532,0.0001527698,0.0001254948,0.01341799,0.00006669975,0.005572801,0.0004434182,0.000381008,0.001886617],"genre_scores_gemma":[0.9866508,0.0003844255,0.002956542,0.001414028,0.001387603,0.0007149588,0.002298175,0.0002729822,0.003920538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0840659,"threshold_uncertainty_score":0.9995896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974511383","doi":"10.1016/j.leukres.2010.05.002","title":"Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Refractory (planetary science); Medicine; Fluorescence in situ hybridization; Cytogenetics; Oncology; Adverse effect; Gastroenterology; Biology; Chromosome","retraction":null,"screen_n_in":null,"score":{"opus":0.03096900406327269,"gpt":0.3650718684054194,"spread":0.3341028643421467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008346107,0.0003300062,0.0007729693,0.0008382255,0.00008188011,0.00001087691,0.0002642678,0.000258234,0.0002186436],"category_scores_gemma":[0.001351421,0.0001759964,0.0001387084,0.001309847,0.0005909477,0.0001173609,0.0001050089,0.00122266,0.00002423981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010572,"about_ca_system_score_gemma":0.00192695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003702538,"about_ca_topic_score_gemma":0.001713252,"domain_scores_codex":[0.9959997,0.0004275716,0.0004596598,0.0005070239,0.001686805,0.000919228],"domain_scores_gemma":[0.9963297,0.00113603,0.0001562843,0.000998982,0.0008661938,0.0005127836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06809998,0.001031579,0.9006935,0.0002542249,0.0004027324,0.0004236135,0.0001473074,0.00003664219,0.02200573,0.000001334188,0.00007435172,0.006829041],"study_design_scores_gemma":[0.04127971,0.02749948,0.8910885,0.0003120344,0.00005371727,0.00001268495,0.00003504513,0.0005532675,0.0389901,8.82719e-7,0.00002801876,0.0001465991],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968643,0.00002179252,0.000002438574,0.00001029284,0.00001412725,0.002284971,0.0001090694,0.000026749,0.0006662705],"genre_scores_gemma":[0.9984862,0.00003080248,0.0006026244,0.000002783817,0.00003026924,0.0001158593,0.0002005765,0.00007781872,0.0004531275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02682026,"threshold_uncertainty_score":0.7176925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985662900","doi":"10.1016/j.leukres.2012.05.020","title":"Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Myeloid leukemia; Quality of life (healthcare); Chemotherapy; Young adult; Gerontology; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07527798105685493,"gpt":0.3864335675960221,"spread":0.3111555865391672,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656535,0.0002000493,0.0006475289,0.0001725538,0.000143611,0.00003276542,0.000111855,0.0001493473,0.00005137004],"category_scores_gemma":[0.0003474877,0.0001626936,0.0001186435,0.0005085634,0.0002238156,0.0001523391,0.00008615979,0.0004940139,0.000007436702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001426697,"about_ca_system_score_gemma":0.0004182896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001201483,"about_ca_topic_score_gemma":0.0003854565,"domain_scores_codex":[0.9976687,0.0001674,0.0002757586,0.0003738056,0.000847356,0.0006669905],"domain_scores_gemma":[0.9977775,0.0003527087,0.00006923154,0.0003835033,0.0009900272,0.0004270284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.04732782,0.0006984426,0.08889934,0.002047725,0.004198239,0.0001024738,0.1640901,0.00002282501,0.6532174,0.0003391422,0.03514116,0.003915277],"study_design_scores_gemma":[0.01396543,0.001248742,0.9042234,0.0004811657,0.0002468162,0.00001063755,0.01217072,0.0003162831,0.06423166,0.00009442625,0.002514414,0.0004963477],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971282,0.0001634208,0.0001490079,0.001015644,0.00009878468,0.0009886787,0.00006887987,0.00004541513,0.0003419574],"genre_scores_gemma":[0.9959642,0.00003058158,0.0000509229,0.001633576,0.0003899465,0.0001397134,0.00008094236,0.00005261195,0.001657468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.815324,"threshold_uncertainty_score":0.6634452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053491031","doi":"10.1016/j.leukres.2008.12.008","title":"Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Perception; Intensive care medicine; Internal medicine; Pediatrics; Family medicine; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.1109130015331027,"gpt":0.4241619655654159,"spread":0.3132489640323132,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007046651,0.0002745918,0.000459269,0.0009204868,0.001191698,0.0000374591,0.001109611,0.0004624691,0.0002876833],"category_scores_gemma":[0.001678527,0.0002063674,0.00006805659,0.002023095,0.0002279129,0.00111415,0.0003725067,0.002357162,0.000552022],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004008747,"about_ca_system_score_gemma":0.005996772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004855809,"about_ca_topic_score_gemma":0.0004268814,"domain_scores_codex":[0.9939635,0.00154448,0.001319842,0.0002016981,0.001738451,0.001231997],"domain_scores_gemma":[0.9917342,0.001668325,0.000419519,0.001651233,0.004124431,0.0004022578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009683965,0.0005679468,0.3475741,0.003214386,0.0002480352,0.00001551427,0.3212962,0.0003668545,0.000496435,0.01156761,0.188182,0.116787],"study_design_scores_gemma":[0.03711556,0.006496747,0.695618,0.005410495,0.00008788935,0.000007568233,0.1680402,0.00270288,0.001526082,0.001439422,0.08026269,0.001292434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980772,0.0001747668,0.0001531222,0.004538934,0.0002519939,0.00398946,0.0001148692,0.0001858022,0.009819021],"genre_scores_gemma":[0.9917084,0.0006219223,0.002153997,0.002646852,0.0001240618,0.0006974288,0.0004139631,0.00004032868,0.001593075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.348044,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011872467","doi":"10.1016/j.leukres.2005.05.010","title":"5-Aza-2′-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"National Cancer Institute; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Decitabine; Trichostatin A; Cancer research; Chromatin remodeling; Myeloid leukemia; Histone; Chromatin; Acetylation; DNA methylation; Chromatin immunoprecipitation; Epigenetics; Chemistry; Methylation; Histone deacetylase inhibitor; Biology; Histone deacetylase; Molecular biology; Promoter; Gene; Gene expression; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03042550730184956,"gpt":0.3676844766699895,"spread":0.33725896936814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002765993,0.0003768271,0.0004604444,0.0004744077,0.0003169719,0.00006415284,0.0005314884,0.0005915709,0.00004000975],"category_scores_gemma":[0.0007179552,0.0003870479,0.0001447182,0.0005916729,0.0002206095,0.00004538445,0.0005151049,0.0008608177,0.00001163356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001711242,"about_ca_system_score_gemma":0.0007775049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001410646,"about_ca_topic_score_gemma":0.0008971101,"domain_scores_codex":[0.9954472,0.0006409294,0.001001123,0.001056574,0.0009699159,0.0008842804],"domain_scores_gemma":[0.9976649,0.00009017679,0.0003415844,0.001082815,0.0005201877,0.0003003218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002992718,0.00009773589,0.0008320467,0.00007378658,0.00005260728,0.0000137138,0.0005030039,0.000928218,0.9917853,0.0001741106,0.0008404583,0.004399732],"study_design_scores_gemma":[0.002150187,0.0005445967,0.000946544,0.0001838931,0.00002951775,0.000006601513,0.0001248524,0.005236987,0.9871148,0.001075194,0.002177402,0.0004093518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931842,0.002865988,0.001968501,0.0003674521,0.00008646487,0.0008108776,0.00003482267,0.00003342435,0.000648249],"genre_scores_gemma":[0.9911861,0.001567853,0.003713596,0.00006570063,0.0003195201,0.0001231495,0.0004628811,0.0001022256,0.002459018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004670441,"threshold_uncertainty_score":0.9998581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094949617","doi":"10.1016/j.leukres.2013.07.020","title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Medicine; Myeloid leukemia; Abortion; Tyrosine-kinase inhibitor; Tyrosine kinase; Pregnancy; Leukemia; Myeloid; Obstetrics; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02018674346074954,"gpt":0.2786858571405371,"spread":0.2584991136797876,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000426864,0.0005894083,0.0007819001,0.0008149325,0.0002501802,0.0001415785,0.0003777274,0.0003330254,0.0008552445],"category_scores_gemma":[0.0001812438,0.0003957715,0.00008602538,0.002067964,0.0006905717,0.0005372079,0.0002236334,0.001498059,0.0009677429],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0335974,"about_ca_system_score_gemma":0.007032144,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00814112,"about_ca_topic_score_gemma":0.001157574,"domain_scores_codex":[0.9941769,0.0002436023,0.000571536,0.001105571,0.00207966,0.001822703],"domain_scores_gemma":[0.9967153,0.0002577323,0.000127133,0.001320175,0.0009770342,0.0006026002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003521312,0.0008646445,0.9621237,0.000682172,0.0002888035,0.0006725784,0.0004565271,0.0002076891,0.004853109,0.00009087411,0.006872384,0.01936622],"study_design_scores_gemma":[0.03885882,0.006621639,0.9305983,0.002572377,0.0000781036,0.00004752195,0.0001458767,0.0008245761,0.01746648,0.00002857786,0.002184274,0.0005734856],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906537,0.0007278764,0.000005918721,0.0003464548,0.00004050925,0.004010222,0.00001955868,0.0001741179,0.004021656],"genre_scores_gemma":[0.9891498,0.0001171672,0.0005964893,0.00009124843,0.0002295617,0.001107134,0.000295222,0.000163533,0.008249809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03533751,"threshold_uncertainty_score":0.9998494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2119733997","doi":"10.1016/j.leukres.2013.03.001","title":"All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Acute promyelocytic leukemia; Medicine; Chemotherapy; Retinoic acid; Randomized controlled trial; Induction chemotherapy; Internal medicine; Surgery; Pediatrics; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.01926125051305213,"gpt":0.299783781594682,"spread":0.2805225310816299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007417101,0.000318346,0.0004132938,0.0001763352,0.0001711889,0.00009515043,0.0009962098,0.000195304,0.00002354134],"category_scores_gemma":[0.0002579907,0.000238545,0.0001319165,0.0007766691,0.0009311165,0.00002876079,0.0007631034,0.0009261167,0.00001587372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004536799,"about_ca_system_score_gemma":0.0008828375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001080906,"about_ca_topic_score_gemma":0.001752475,"domain_scores_codex":[0.9966735,0.000571756,0.0005389692,0.0007676031,0.0006599539,0.0007882593],"domain_scores_gemma":[0.9983273,0.00008651211,0.000163265,0.0009592132,0.0002992767,0.000164399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003834112,0.0001303406,0.6537257,0.0002149351,0.0002445449,0.00005327812,0.001116973,0.00002991935,0.3387704,0.000005504671,0.0005584887,0.00476644],"study_design_scores_gemma":[0.003127564,0.001481103,0.7459474,0.0001270414,0.00007903205,0.00004283663,0.0008744075,0.0001276927,0.2474437,0.00006015669,0.0002680397,0.0004209912],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974359,0.0005770858,0.0000283855,0.000166219,0.0001271954,0.001232564,0.000009038805,0.00001644134,0.0004071439],"genre_scores_gemma":[0.9964361,0.001080463,0.00006381685,0.00009208522,0.00009453819,0.0002912569,0.00004176296,0.00005571172,0.001844291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09222168,"threshold_uncertainty_score":0.9727584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}